Transactional

Tech Collaborations – Harnessing potential whilst balancing risk

Megan McMellon

On 18 June, Google and Sanofi announced a new collaboration aimed at accelerating healthcare innovation. The collaboration has three key objectives: to better understand patients and diseases; to increase Sanofi’s operational efficiency; and to improve the experience of Sanofi’s patients and customers. Google and Sanofi will develop an Innovation Lab to test and explore both Read More

New German Appointment Service and Supply Act: Implications for investors in the dental industry

Eda Zhuleku

On 14 March 2019, the German Parliament (Bundestag) adopted the German Appointment Service and Supply Act (Terminservice- und Versorgungsgesetz; TSVG), which will come into force in May 2019, as the German Federal Council (Bundesrat) did not veto the law. During the legislative process, it was feared that the Act would have significant impact on the Read More

Coordination amongst member states on medicines’ prices supported by the European Commission

Nele De Backer

European Commissioner for Health and Food Safety, Vytenis Andriukaitis, said that the European Commission will support national competition authorities in their probes against excessive pricing practices in pharmaceutical markets. In addition, the European Commission will continue to monitor pharmaceutical markets itself, as part of its competition policy, and is ready to act against infringements of Read More

Rethinking the Growth Capital Challenge in UK Life Sciences

Matthew Appleton

Investors, entrepreneurs and deal makers in the UK Life Sciences industry met on the 28 September 2018 to share ideas on how to close the funding gap which exists for UK businesses in the period between early stage investment and IPO. At a lively panel discussion sponsored by LSX Connect and hosted by Allen & Read More

Life Sciences IPOs – 5 things to consider

Michael Bloch

After spending all day last Wednesday at Biotech & Money’s IPO workshop presenting and talking to Life Sciences start ups about their IPO plans, we thought it might be interesting to bring together some of our key thoughts on IPO preparedness. Companies thinking about an IPO can never start planning too early.  IPO planning and Read More